Literature DB >> 3879376

Symptoms in patients with peptic ulcer and hematemesis and/or melena related to the use of non-steroid anti-inflammatory drugs.

H Mellem, R Stave, J Myren, M Osnes, L E Hanssen, J Mosvold, K Hebnes.   

Abstract

One hundred and seven consecutive patients with hematemesis and/or melena and a diagnosis of duodenal, gastric, or esophageal ulcers were interviewed immediately before or after endoscopy about the use of non-steroid anti-inflammatory drugs (NSAIDs) and symptoms before the hemorrhage. If the patients admitted no symptoms of abdominal pain or discomfort, nausea, vomiting, or heartburn, they were classified as having no ulcer symptoms before the hemorrhage. Patients who had not taken NSAIDs during the last 48 h before the hemorrhage were classified as not having taken NSAIDs. Significantly fewer patients had ulcer symptoms in the group that had used NSAIDs than in the other group (p less than 0.01). This may be interpreted as a possible masking effect by NSAIDs on ulcer symptoms. Physicians and patients should be aware of this possible effect of NSAIDs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3879376     DOI: 10.3109/00365528509089284

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Placebo-controlled comparison of piroxicam-beta-cyclodextrin, piroxicam, and indomethacin on gastric potential difference and mucosal injury in humans.

Authors:  L Santucci; S Fiorucci; S Chiucchiù; A Sicilia; L Bufalino; A Morelli
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

Review 2.  Asymptomatic peptic ulcer disease. Is it worth looking for?

Authors:  R Corinaldesi; R De Giorgio; A Paternicò; V Stanghellini
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

3.  The cost effectiveness of diclofenac plus misoprostol compared with diclofenac monotherapy in patients with rheumatoid arthritis.

Authors:  M J Al; B C Michel; F F Rutten
Journal:  Pharmacoeconomics       Date:  1996-08       Impact factor: 4.981

4.  Asymptomatic peptic ulcer disease.

Authors:  M J Dew
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-15

5.  Bleeding peptic ulcer occurring in hospitalized patients: analysis of predictive and risk factors and comparison with out-of-hospital onset of hemorrhage.

Authors:  S Loperfido; F Monica; L Maifreni; A Paccagnella; R Famà; R Dal Pos; C Sartori
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

6.  Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs.

Authors:  N Hudson; M Balsitis; F Filipowicz; C J Hawkey
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

7.  Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.

Authors:  R S Ehsanullah; M C Page; G Tildesley; J R Wood
Journal:  BMJ       Date:  1988-10-22

8.  Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs.

Authors:  M G Robinson; J W Griffin; J Bowers; F J Kogan; D G Kogut; F L Lanza; C W Warner
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

Review 9.  Treatment of peptic ulcer disease in the arthritic patient.

Authors:  D Nunes; N P Kennedy; D G Weir
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

10.  Association of diabetes and HbA1c levels with gastrointestinal manifestations.

Authors:  Ping-Huei Tseng; Yi-Chia Lee; Han-Mo Chiu; Chien-Chuan Chen; Wei-Chih Liao; Chia-Hung Tu; Wei-Shiung Yang; Ming-Shiang Wu
Journal:  Diabetes Care       Date:  2012-03-12       Impact factor: 19.112

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.